Advances in Precision Cancer Therapy

Dear Colleagues,

Cancer precision therapy utilizes a range of techniques, such as genomic analysis and molecular diagnostics, to identify specific genetic and molecular abnormalities in cancer cells and design treatments that selectively target these abnormalities. This approach can lead to more effective and personalized cancer treatment plans, improved patient outcomes, and fewer side effects.

The scope of cancer precision therapy includes targeted therapies, immunotherapies, and other emerging approaches such as CAR-T cell therapy. These therapies can also be used in combination with other cancer treatments, such as chemotherapy and radiotherapy, to improve their effectiveness. The field of cancer precision therapy has been evolving in recent years, with new techniques and methods being developed to improve the accuracy and effectiveness of cancer treatments.

In this Special Issue, we welcome research and review articles focusing on the recent advances in the field of cancer precision therapy.

Prof. Dr. Yongheng Chen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.